Inovio Pharmaceuticals Inc (INO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.79
• Market Cap: $127.10M
• EPS: $-2.66
• 52-Week High: $2.98
• 52-Week Low: $1.30

Market Sentiment

Inovio Pharmaceuticals Inc currently has a Bearish sentiment score of -0.56.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc. is a cutting-edge biotechnology company dedicated to developing innovative DNA-based therapeutics aimed at treating a range of diseases, including cancer and infectious diseases such as HPV. Leveraging its proprietary platform, Inovio stands at the forefront of immunotherapy advancements and has cultivated a diverse pipeline of product candidates designed to meet significant unmet medical needs. The firm’s ongoing clinical research initiatives reflect its commitmen...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Inovio Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INO pay dividends?

Inovio Pharmaceuticals Inc (INO) does not currently pay a regular dividend.

What is INO's market cap?

Inovio Pharmaceuticals Inc (INO) has a market capitalization of $127.10M with a current stock price of $1.79.